0001209191-20-010324.txt : 20200218
0001209191-20-010324.hdr.sgml : 20200218
20200218180310
ACCESSION NUMBER: 0001209191-20-010324
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200213
FILED AS OF DATE: 20200218
DATE AS OF CHANGE: 20200218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FARBER STEPHEN D
CENTRAL INDEX KEY: 0001205449
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12111
FILM NUMBER: 20626741
MAIL ADDRESS:
STREET 1: 680 SOUTH FOURTH STREET
CITY: LOUISVILLE
STATE: KY
ZIP: 40202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDNAX, INC.
CENTRAL INDEX KEY: 0000893949
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060]
IRS NUMBER: 263667538
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1301 CONCORD TERRACE
CITY: SUNRISE
STATE: FL
ZIP: 33323
BUSINESS PHONE: 9543840175
MAIL ADDRESS:
STREET 1: 1301 CONCORD TERRACE
CITY: SUNRISE
STATE: FL
ZIP: 33323
FORMER COMPANY:
FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC
DATE OF NAME CHANGE: 19950801
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-13
0
0000893949
MEDNAX, INC.
MD
0001205449
FARBER STEPHEN D
1301 CONCORD TERRACE
SUNRISE
FL
33323
0
1
0
0
Chief Financial Officer
Common Stock
2020-02-13
4
A
0
88791
0.00
A
238742
D
Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 22,198 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2020. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on March 1, 2021, March 1, 2022 and March 1, 2023, subject to the terms of the Plan.
/s/ Dominic J. Andreano, Attorney-in-Fact
2020-02-18